Mary Hammon
Professor Charles Yankah has dedicated the last fifty years to advancing cardiovascular care and helping the globally underserved communities who require it. Since his retirement from cardiothoracic and vascular surgery at the German Heart Center...
Professor Charles Yankah has dedicated the last fifty years to advancing cardiovascular care and helping the globally underserved communities who require it. Since his retirement from cardiothoracic and vascular surgery...
August’s top content includes several items from our recent Guest Editor Series, “Segmentectomy for Lung Cancer,” from guest editor Alan Sihoe, as well as two uniportal technique videos from thoracic...
A new analysis by a team led by Dr. Mario Gaudino of Weill Cornell Medicine and NewYork-Presbyterian shows that a combination of two antiplatelets drugs can benefit patients after coronary...
Surgical management for potentially resectable stage IIIA-N2 non-small cell lung cancer (NSCLC) is controversial. In this study, researchers examined outcomes of a well-selected surgical cohort of postinduction IIIA-N2 NSCLC patients...
A year ago, a twelve-year-old girl became the youngest person in Canada undergo surgery to receive a total artificial heart. The device, which can essentially replace an entire human heart...
The modified Blalock-Taussig-Thomas shunt is an important palliation for patients with insufficient pulmonary blood flow associated with congenital heart disease. This study found increased morbidity and mortality tied to smaller...
A group of cardiac surgeons and general cardiologists critical of what they believe is biased data in coronary and structural heart disease has founded a group called the International Evidence...
With all the great video submissions we’ve received from CT surgeons around the world, it’s hard not to get excited about the future of cardiothoracic surgery! To wrap up our...
Adequate postoperative pain management after thoracic surgery is crucial to prevent of respiratory complications, but use of morphine can be problematic for some patients. This study evaluated the impact of...
We’re halfway through the year, and the international cardiothoracic community has been busy sharing techniques and practices with peers around the world via CTSNet. Over the last few weeks, we...
Can you believe it’s already July? In the first half of 2022, CTSNet has had surgeons from countless parts of the world share their valuable experience and expertise with our...
In January 2022, University of Maryland School of Medicine surgeon-scientists made history by successfully implanting a genetically modified pig heart into a fifty-seven-year-old patient in end-stage heart failure who did...





